Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDER final printed labeling electronic submission pilot program slated to begin in early 1997.

Executive Summary

NDA FINAL PRINTED LABELING ELECTRONIC SUBMISSION PILOT PROGRAM is scheduled to begin in early 1997, FDA Center for Drug Evaluation & Research Director Janet Woodcock, MD, told the Food & Drug Law Institute's educational conference in Washington, D.C. Dec. 10. Under development by FDA and the Pharmaceutical Research & Manufacturers of America, the program will allow companies to submit final labeling electronically in lieu of multiple paper copies. Eventually, FDA expects to use the Internet to conduct negotiations over final labeling as well.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS029340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel